VOYA Investment Management
FENC icon

VOYA Investment Management’s Fennec Pharmaceuticals FENC Stock Holding History

VOYA Investment Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-11,004
Closed -$68K – 2840
2021
Q1 		$68K Buy
+11,004
New +$82.8K ﹤0.01% 2720

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

VOYA Investment Management's FENC Position: Q2 2021 in Review

VOYA Investment Management sold out of Fennec Pharmaceuticals (FENC) in Q2 2021, closing a stake of 11,004 shares — an estimated $68K sold.

VOYA Investment Management first reported a position in FENC in Q1 2021 and held it in 1 quarter. The position peaked at $68K in Q1 2021. 39 funds tracked by Wall St. Rank hold FENC as of Q2 2021.

  • VOYA Investment Management reported no remaining Fennec Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • VOYA Investment Management sold 11,004 Fennec Pharmaceuticals shares in Q2 2021, an estimated $68K.
  • VOYA Investment Management first reported a position in Fennec Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • VOYA Investment Management's Fennec Pharmaceuticals position peaked at $68K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.